This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 1969;40(6):925-45.

Evidence on the safety and efficacy of live poliomyelitis vaccines currently in use, with special reference to type 3 poliovirus

No authors listed

PMID: 4310724
PMCID: PMC2554752

Evidence on the safety and efficacy of live poliomyelitis vaccines currently in use, with special reference to type 3 poliovirus

No authors listed. Bull World Health Organ. 1969.

. 1969;40(6):925-45.

PMID: 4310724
PMCID: PMC2554752

No abstract available

PubMed Disclaimer

Similar articles

[Excretion rates after Sabin oral vaccination against poliomyelitis in Tyrol].
Bauer P. Bauer P. Arch Hyg Bakteriol. 1968 Dec;152(5):410-4. Arch Hyg Bakteriol. 1968. PMID: 4313799 German. No abstract available.
Poliomyelitis surveillance in Kabul City. II.
Thraenhart O, Omar A, Habib A, Miakhail MR. Thraenhart O, et al. Zentralbl Bakteriol Orig. 1970 Apr;213(3):319-24. Zentralbl Bakteriol Orig. 1970. PMID: 4318511 No abstract available.
Studies on new attenuated strains of type III live poliomyelitis vaccine. II. Field trials of Zhong III2 virus.
[No authors listed] [No authors listed] Chin Med J (Engl). 1980 Sep;93(9):591-8. Chin Med J (Engl). 1980. PMID: 6253237 Clinical Trial. No abstract available.
A new type 3 attenuated poliovirus for possible use in oral poliovirus vaccine.
Vonka V, Janda Z, Simon J, Adam E, Stárek M. Vonka V, et al. Prog Med Virol. 1967;9:204-55. Prog Med Virol. 1967. PMID: 4293687 Review. No abstract available.
Safety aspects of oral poliovirus vaccine campaigns.
Hovi T. Hovi T. Dev Biol Stand. 1995;84:137-44. Dev Biol Stand. 1995. PMID: 7796946 Review. No abstract available.

See all similar articles

Cited by

Questions regarding the safety and duration of immunity following live yellow fever vaccination.
Amanna IJ, Slifka MK. Amanna IJ, et al. Expert Rev Vaccines. 2016 Dec;15(12):1519-1533. doi: 10.1080/14760584.2016.1198259. Epub 2016 Jun 20. Expert Rev Vaccines. 2016. PMID: 27267203 Free PMC article. Review.

References

1. JAMA. 1965 Nov 22;194(8):872-6 - PubMed
1. Am J Epidemiol. 1966 Jan;83(1):130-45 - PubMed
1. Am J Epidemiol. 1966 May;83(3):501-8 - PubMed
1. Prog Med Virol. 1967;9:204-55 - PubMed
1. Am J Epidemiol. 1968 Mar;87(2):396-410 - PubMed

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Europe PubMed Central
- PubMed Central